山西振东制药回购进展：已回购1301.67万股，金额达5203.09万元

Group 1 - The company Shanxi Zhendong Pharmaceutical Co., Ltd. announced the progress of its share repurchase plan as of August 31, 2025 [1] - The share repurchase plan was approved on October 22 and November 12, 2024, with a total repurchase fund limit of 100 million yuan and a minimum of 50 million yuan, at a price not exceeding 6 yuan per share [2] - The maximum repurchase price was later adjusted to not exceed 11.4 yuan per share, while other terms remained unchanged [2] Group 2 - As of August 31, 2025, the company repurchased a total of 13.0167 million shares, accounting for 1.29% of the total share capital, with a total transaction amount of 52.0309 million yuan [3] - The highest transaction price was 10.06 yuan per share, and the lowest was 3.51 yuan per share [3] - The company's share repurchase activities complied with relevant regulations and guidelines [4]